These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31332417)

  • 1. Investigation of binding and activity of perfluoroalkyl substances to the human peroxisome proliferator-activated receptor β/δ.
    Li CH; Ren XM; Cao LY; Qin WP; Guo LH
    Environ Sci Process Impacts; 2019 Nov; 21(11):1908-1914. PubMed ID: 31332417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ.
    Zhang L; Ren XM; Wan B; Guo LH
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):275-283. PubMed ID: 24998974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
    Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells.
    Rosenmai AK; Ahrens L; le Godec T; Lundqvist J; Oskarsson A
    J Appl Toxicol; 2018 Feb; 38(2):219-226. PubMed ID: 28857218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies towards the conception of new selective PPARbeta/delta ligands.
    Basséne CE; Suzenet F; Hennuyer N; Staels B; Caignard DH; Dacquet C; Renard P; Guillaumet G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4528-32. PubMed ID: 16797985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Δ
    Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
    Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.
    Giordano Attianese GM; Desvergne B
    Nucl Recept Signal; 2015; 13():e001. PubMed ID: 25945080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
    Aleshin S; Reiser G
    Mol Cell Neurosci; 2014 Mar; 59():127-34. PubMed ID: 24513118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding.
    Schwarz R; Tänzler D; Ihling CH; Sinz A
    PLoS One; 2016; 11(3):e0151412. PubMed ID: 26992147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and activity of bisphenol analogues to human peroxisome proliferator-activated receptor β/δ.
    Li CH; Zhang DH; Jiang LD; Qi Y; Guo LH
    Ecotoxicol Environ Saf; 2021 Dec; 226():112849. PubMed ID: 34627044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids.
    Zhu B; Zhu X; Borland MG; Ralph DH; Chiaro CR; Krausz KW; Ntambi JM; Glick AB; Patterson AD; Perdew GH; Gonzalez FJ; Peters JM
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Silico Evaluations of Binding Affinities of Perfluoroalkyl Substances to Baikal Seal and Human Peroxisome Proliferator-Activated Receptor α.
    Ishibashi H; Hirano M; Kim EY; Iwata H
    Environ Sci Technol; 2019 Feb; 53(4):2181-2188. PubMed ID: 30649875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.